article thumbnail

Global Healthcare Industry – M&A and Capital Market Landscape Update

Evalueserve

On the other hand, Biotech heavily underperformed post Q1’21 primarily due to the shifting of focus towards cyclicals and negative sentiments arising as of result of greater regulatory clampdown on transformative deals and drug pricing. Sponsor deals rebounded exceptionally.

Capital 98
article thumbnail

Engage3 Team

Engage3

Ken Ouimet, PhD Founder/Chairman, Technology Committee Ken Ouimet is the Chair of Strategic Planning and Founder of Engage3 and is credited with creating the retail revenue management and price optimization market. Bryan studied Electronics Control Systems at Technological University Dublin. Mary Bunting Sr.

Retail 52